Stryker, based in Kalamazoo, Mich., said it decided to withdraw from the global hip resurfacing market due to business factors such as changing market opportunities. Corin will resume direct distribution of the system.
Stryker began distributing Cirencester, United Kingdom-based Corin’s Cormet hip resurfacing device in the United States after it won FDA approval in 2007."Distribution of a hip resurfacing device no longer fits within Stryker's long-term product strategy," said Stuart Simpson, vice president of Stryker Orthopaedics’ Global Hip Reconstruction Marketing. According to the company, the decision was based on changing market opportunities as well as the changing ownership of the supplier that manufactures the MITCH product line, which is distributed in international markets.
The companies are working together to ensure a smooth transition, according to a press release.